Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

December 2021

Kinetochem, LLC (PDF) (December 6, 2021)

Johnson Matthey Inc. (PDF) (December 6, 2021)

Fisher Clinical Services, Inc. (PDF) (December 6, 2021)

Final Order: Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022 (PDF) (December 2, 2021)


November

IsoSciences, LLC (PDF) (November 29, 2021)

API Manufacturing, Inc. (PDF) (November 29, 2021)

Pisgah Laboratories Inc. (PDF) (November 29, 2021)

Noramco (PDF) (November 23, 2021)

Mylan Technologies, Inc. (PDF) (November 23, 2021)

Proposed Rule: Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances between Pharmacies for Initial Filling (PDF) (November 19, 2021)

Final Rule: Designation of Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical (PDF) (November 18, 2021)

Pronto Pharmacy, LLC; Decision and Order (PDF) (November 18, 2021)

Proposed Rule: Regulation of Telepharmacy Practice (PDF) (November 17, 2021)

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 (PDF) (November 15, 2021)

George Roussis, M.D.; Decision and Order (PDF) (November 5, 2021)

Larry C. Daniels, M.D.; Decision and Order (PDF) (November 5, 2021)

Proposed Rule: Removal of [\18\F]FP-CIT From Control (PDF) (November 4, 2021)

Final Order: Placement of Isotonitazene in Schedule I (PDF) (November 4, 2021)

Nanosyn Inc. (PDF) (November 3, 2021)

Groff Global (PDF) (November 3, 2021)

Fisher Clinical Services, Inc. (PDF) (November 3, 2021)


October

30-Day Notice: Recordkeeping for Electronic Prescriptions for Controlled Substances (PDF) (November 2, 2021)

Novitium Pharma LLC (PDF) (October 26, 2021)

Nicholas P. Roussis, M.D.; Decision and Order (PDF) (October 26, 2021)

Maura Tuso, D.M.D.' Decision and Order (PDF) (October 26, 2021)

Globyz Pharma, LLC (PDF) (October 26, 2021)

Indigenous Peyote Conservation Initiative (PDF) (October 26, 2021)

30-Day Notice: Recordkeeping for Electronic Prescriptions for Controlled Substances (PDF) (October 25, 2021)

Chattem Chemicals (PDF) (October 22, 2021)

Groff NA Hemplex LLC (PDF) (October 22, 2021)

Organic Consultants, LLC DBA Cascade Chemistry (PDF) (October 22, 2021)

Mycrodose Therapeutics (PDF) (October 22, 2021)

Novitium Pharma LLC (PDF) (October 22, 2021)

Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022 (PDF) (October 18, 2021)

United States Pharmaceopeial Convention (PDF) (October 12, 2021)

New Mexico Top Organics-Ultra Health (PDF) (October 7, 2021)

AndersonBrecon, Inc. (PDF) (October 7, 2021)

Caligor Coghlan Pharma Services (PDF) (October 7, 2021)

William C. Gardner, D.D.S.; Decision and Order (PDF) (October 1, 2021)

Darryl L. Henry, M.D.; Decision and Order (PDF) (October 1, 2021)

Pharmacy 4 Less; Decision and Order (PDF) (October 1, 2021)


September

Cambridge Isotope Laboratories, Inc. (PDF) (September 29, 2021)

30-Day Notice: Extension; Application for Registration Renewal DEA Forms 363, 363a (PDF) (September 28, 2021)

Groff NA Hemplex, LLC (PDF) (September 27, 2021)

PCI Synthesis (PDF) (September 24, 2021)

Cardinal Health (PDF) (September 24, 2021)

30-Day Notice: Extension; Application for Registration Renewal, DEA Forms 363, 363a (PDF) (September 23, 2021)

Salman Akbar, M.D.; Decision and Order (PDF) (September 20, 2021)

Humberto A. Florian, M.D.; Decision and Order (September 20, 2021)

Steven P. French, M.D.; Decision and Order (September 20, 2021)

Lisa M. Jones, N.P.; Dismissal of Proceedings (September 20, 2021)

Final Rule: Addition of the United States Space Force as a Registration Waiver and Registration Fee Exempt Military Entity (September 17, 2021)

Cambridge Isotope Laboratories (September 15, 2021)

Amethyst Exploration, LLC (September 13, 2021)

Eli-Elsohly Laboratories (September 13, 2021)

Cayman Chemical Company (September 13, 2021)

Aurobindo Pharma USA, Inc. (September 13, 2021)

Uvienome Linda Sakor, N.P.; Decision and Order (September 7, 2021)

Lora L. Thaxton, M.D.; Decision and Order (September 7, 2021)

Proposed Rule: Placement of Methiopropamine in Schedule I (September 2, 2021)

Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 (September 2, 2021)


August

Chemtos, LLC (August 27, 2021)

Cambrex Charles City (August 27, 2021)

Benuvia Therapeutics Inc. (August 25, 2021)

Absolute Standards, Inc. (August 25, 2021)

Cedarburg Pharmaceuticals (August 25, 2021)

Johnson Matthey Inc. (August 25, 2021)

Galephar Pharmaceutical Research Inc. (August 19, 2021)

Chattem Chemicals, Inc. (August 19, 2021)

Catalent CTS, LLC (August 13, 2021)

Final Rule: Placement of 4,4'-DMAR in Schedule I (August 12, 2021)

PA Options for Wellness, Inc. (August 12, 2021)

Epic Pharma, LLC (August 12, 2021)

Globyz Pharma, LLC (August 12, 2021)

Cambrex High Point, Inc. (August 12, 2021)

MP Pharma Services (August 12, 2021)

Curium US, LLC (August 12, 2021)

Proposed Rule: Placement of Mesocarb in Schedule I (August 11, 2021)

Cambrex High Point, Inc. (August 5, 2021)

Purisys, LLC (August 3, 2021)

Cerilliant Corporation (August 3, 2021)

AMRI Rensselaer, Inc. (August 2, 2021)


July

AMPAC Fine Chemicals, LLC (July 29, 2021)

Nusachi Labs, LLC (July 29, 2021)

Cerilliant Corporation (July 29, 2021)

Purisys, LLC (July 29, 2021)

Care Point Pharmacy, Inc.; Decision and Order (July 28, 2021)

Creekbend Community Pharmacy; Decision and Order (July 28, 2021)

William Ralph Kinkaid, M.D.; Decision and Order (July 28, 2021)

Erica N. Grant, M.D.; Decision and Order (July 28, 2021)

Novitium Pharma, LLC (July 27, 2021)

Catalent Pharma Solutions, LLC (July 27, 2021)

Arizona Department of Corrections (July 23, 2021)

Order with Opportunity for Comment: Exempt Chemical Preparations Under the Controlled Substances Act (PDF) (July 22, 2021)

Proposed Rule: Placement of Amineptine in Schedule I (July 22, 2021)

Direct Final Rule: Clarification Regarding the Supplier's DEA Registration Number on the Single-Sheet DEA Form 222 (July 20, 2021)

Proposed Rule: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4'-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4'-Chloro-alpha-pyrrolidinovalerophenone in Schedule I (July 16, 2021)

Extension of Temporary Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4'-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4'-Chloro-alpha-pyrrolidinovalerophenone in Schedule I of the Controlled Substances Act (July 16, 2021)

Alcami Carolinas Corporation (July 8, 2021)

Aspen API, Inc. (July 8, 2021)

30-Day Notice: Exempt Chemical Preparations Application (July 6, 2021)

Spring Valley Family Pharmacy; Decision and Order (July 2, 2021)

Keith A. Jenkins, N.P.; Decision and Order (July 2, 2021)

United States Pharmacopeial Convention (July 2, 2021)

Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility